Quality Risk Evaluation for New Product Introduction Non-Sterile Solid Oral Dosage Forms

by

Quality Risk Assessment for Solid Oral Dosage Forms

Non-Sterile Solid Oral Dosage Forms

Quality Risk Evaluation for New Product Introduction Non-Sterile Solid Oral Dosage Forms

🎯 OBJECTIVE
Evaluate and control quality risks before introducing a new solid oral dosage product to ensure patient safety, product quality, GMP compliance, and process robustness.

🔍 KEY RISK AREAS

1️⃣ Product & Formulation

  • API/excipient compatibility
  • CQAs: assay, dissolution, content uniformity, impurities
  • API characteristics: particle size, flow, moisture
  • Stability & degradation risks

2️⃣ Manufacturing Process

  • Dispensing → sifting → blending → granulation → drying → compression/capsulation → coating
  • CPP identification
  • Blend uniformity & segregation risk
  • Over/under lubrication
  • Compression & coating parameters

3️⃣ Facility & Utilities

  • Area suitability & capacity
  • HVAC and pressure differentials
  • Temperature & humidity control
  • Purified Water / compressed air, where applicable
  • Material & personnel flow

4️⃣ Cross-Contamination

  • Previous-product residue
  • Dust generation and carryover
  • Dedicated/shared equipment assessment
  • Potent/sensitizing materials
  • Cleaning effectiveness

5️⃣ Equipment

  • Equipment suitability & capacity
  • Product-contact material compatibility
  • Equipment qualification
  • Calibration requirements
  • Cleaning and changeover requirements

6️⃣ Cleaning & Validation

  • Cleaning validation
  • Maximum allowable carryover
  • Dirty/clean hold times
  • Process validation
  • Analytical method suitability

7️⃣ Packaging

  • Container-closure compatibility
  • Moisture/light protection
  • Packaging-line suitability
  • Mix-up and label-control risks
  • Line clearance

8️⃣ Personnel & Documentation

  • Operator training & qualification
  • SOPs and batch manufacturing records
  • Change Control
  • Deviation/CAPA
  • QRM/FMEA documentation

RISK ASSESSMENT FLOW

New Product
↓
Identify Hazards
↓
Assess Risk — Severity × Occurrence × Detectability
↓
FMEA / Risk Matrix
↓
Define Risk Controls
↓
Qualification & Validation
↓
QA Approval
↓
Continued Process & Quality Monitoring

QA FOCUS

“Before introducing a new solid oral dosage product, evaluate formulation, process, equipment, facility, cross-contamination, cleaning, packaging, and personnel risks—and ensure identified risks are adequately controlled through QRM, qualification, and validation.”

Interview Keywords:
CQA • CPP • QRM • FMEA • Process Validation • Cleaning Validation • Cross-Contamination • Blend Uniformity • Dissolution • Content Uniformity • Stability • GMP

Views: 90